Clinical Focus ›› 2021, Vol. 36 ›› Issue (11): 991-995.doi: 10.3969/j.issn.1004-583X.2021.11.006

Previous Articles     Next Articles

Clinical analysis of serum homocysteine in patients with acute ischemic stroke

Zhou Haitaoa,b(), Huang Chaob, Wang Haob, Liu Ruihuab, Du Yanjiaob, Ren Xiangyangb   

  1. a. Central Laboratory; b. Department of Neurology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang 471009, China
  • Received:2021-05-28 Online:2021-11-20 Published:2021-12-01
  • Contact: Zhou Haitao


Objective To retrospectively analyze the clinical characteristics of serum homocysteine(HCY) in patients with acute ischemic stroke(AIS) for the risk factors associated with increased HCY in AIS secondary prevention. Methods A restrespective study was performed in 1 055 patients diagnozed AIS by diffusion weighted imaging(DWI) and apparent diffusion coefficient(ADC) sequence of cranial MRI in our hospital from January 2019 to December 2019. General informations and HCY levels were based on gender and age. The T test or one-way analysis of variance(ANOVA) method was used to compare the difference between groups and binary Logistic regression method was used to analyze the risk factors for HCY. Results The age range for 1 055 AIS patients was 28 to 98 years, (66.4±11.7) years, HCY 3.7-115.5 μmol/L, (20.1±13.0) μmol/L. The stratified analysis based on gender showed that the age of female was significantly increased when comparing with males, while HCY of female was significantly decreased (all P<0.05). The stratified analysis based on the combination of gender and age showed the difference was not statistically significant in HCY level in males in different age groups (P>0.05). HCY level in females were different and HCY of patients aged over 80 years was significantly increased than aged under 50 years and aged 71-80 years (all P<0.05). Binary logistic regression analysis showed that the independent risk factors for HCY were male, age, and type 2 diabetes mellitus. Conclusion Higher HCY are noted in male, elderly, T2DM of AIS patients, the reduction of HCY may allow the patients to obtain greater benefits in the secondary prevention.

Key words: stroke, brain ischemia, homocysteine, risk factors

CLC Number: